NIVF
NewGenIvf Group Limited
NASDAQ · THHealthcareMedical - Healthcare Plans
$1.31-0.76%
Price as of Jul 20, 2026
NIVF profitability
NewGenIvf Group Limited profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 33.6%
- EBITDA margin
- 179.8%
- EBIT margin
- -153.3%
- Net margin
- 165.5%
- Free cash flow margin
- -305.8%
Returns
- Return on equity
- 33.9%
- Return on assets
- 27.6%
- Return on invested capital
- -26.5%
- Asset turnover
- 0.16x
Cash efficiency
- Cash from operations
- -$10.9M
- Cash per share
- $1.33
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.